Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 2
2020 1
2022 2
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.
Meroni PL, Croci S, Lonati PA, Pregnolato F, Spaggiari L, Besutti G, Bonacini M, Ferrigno I, Rossi A, Hetland G, Hollan I, Cugno M, Tedesco F, Borghi MO, Salvarani C. Meroni PL, et al. Among authors: ferrigno i. Autoimmun Rev. 2023 Jan;22(1):103232. doi: 10.1016/j.autrev.2022.103232. Epub 2022 Nov 19. Autoimmun Rev. 2023. PMID: 36414219 Free PMC article. Review.
miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis.
Bonacini M, Rossi A, Ferrigno I, Muratore F, Boiardi L, Cavazza A, Bisagni A, Cimino L, De Simone L, Ghidini A, Malchiodi G, Corbera-Bellalta M, Cid MC, Zerbini A, Salvarani C, Croci S. Bonacini M, et al. Among authors: ferrigno i. J Autoimmun. 2024 Apr;144:103186. doi: 10.1016/j.jaut.2024.103186. Epub 2024 Feb 29. J Autoimmun. 2024. PMID: 38428111
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study).
Sicuranza A, Ferrigno I, Abruzzese E, Iurlo A, Galimberti S, Gozzini A, Luciano L, Stagno F, Russo Rossi A, Sgherza N, Cattaneo D, Zuanelli Brambilla C, Marzano C, Fava C, Mulas O, Cencini E, Santoni A, Sammartano V, Gozzetti A, Puccetti L, Bocchia M. Sicuranza A, et al. Among authors: ferrigno i. Front Oncol. 2022 Feb 1;12:835563. doi: 10.3389/fonc.2022.835563. eCollection 2022. Front Oncol. 2022. PMID: 35178353 Free PMC article.
Validation of a double-color ELISpot assay of IFN-γ and IL-4 production in human peripheral blood mononuclear cells.
Dapporto F, De Tommaso D, Marrocco C, Piu P, Semplici C, Fantoni G, Ferrigno I, Piccini G, Monti M, Vanni F, Razzano I, Manini I, Montomoli E, Manenti A. Dapporto F, et al. Among authors: ferrigno i. J Immunol Methods. 2024 Jan;524:113588. doi: 10.1016/j.jim.2023.113588. Epub 2023 Nov 29. J Immunol Methods. 2024. PMID: 38040193 Free article.
CCL18, CHI3L1, ANG2, IL-6 systemic levels are associated with the extent of lung damage and radiomic features in SARS-CoV-2 infection.
Ferrigno I, Verzellesi L, Ottone M, Bonacini M, Rossi A, Besutti G, Bonelli E, Colla R, Facciolongo N, Teopompi E, Massari M, Mancuso P, Ferrari AM, Pattacini P, Trojani V, Bertolini M, Botti A, Zerbini A, Giorgi Rossi P, Iori M, Salvarani C, Croci S. Ferrigno I, et al. Inflamm Res. 2024 Apr;73(4):515-530. doi: 10.1007/s00011-024-01852-1. Epub 2024 Feb 3. Inflamm Res. 2024. PMID: 38308760
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab.
Cencini E, Sicuranza A, Fabbri A, Ferrigno I, Rigacci L, Cox MC, Raspadori D, Bocchia M. Cencini E, et al. Among authors: ferrigno i. Br J Haematol. 2019 Jan;184(2):223-231. doi: 10.1111/bjh.15582. Epub 2018 Sep 11. Br J Haematol. 2019. PMID: 30203425 Free article. Clinical Trial.
11 results